1080: Ralph P , et al. Lysozyme synthesis by established human and murine histiocytic lymphoma cell lines. J. Exp. Med. 143: 1528-1533, 1976. PubMed:
21866: Gene expression during normal and malignant differentiation. 143: London: Academic Press; 1985, pp. 57-72.
21876: International symposium on new trends in human immunology and cancer immunotherapy. Paris: Doin Editeurs; 1980, pp. 271-292.
22906: Koren HS , et al. In vitro activation of a human macrophage-like cell line. Nature 279: 328-331, 1979. PubMed:
450085 22912: Gidlund M , et al. Natural killer cells kill tumour cells at a given stage of differentiation. Nature 292: 848-850, 1981. PubMed:
23049: Olsson I , et al. Induction of differentiation of the human histiocytic lymphoma cell line U-937 by 1 alpha,25-dihydroxycholecalciferol. Cancer Res. 43: 5862-5867, 1983. PubMed:
23103: Morimoto H , et al. Overcoming tumor necrosis factor and drug resistance of human tumor cell lines by combination treatment with anti-Fas antibody and drugs or toxins. Cancer Res. 53: 2591-2596, 1993. PubMed:
29094: Giovannangeli C , et al. Accessibility of nuclear DNA to triplex-forming oligonucleotides: The integrated HIV-1 provirus as a target. Proc. Natl. Acad. Sci. USA 94: 79-84, 1997. PubMed:
29139: Brigino E , et al. Interleukin 10 is induced by recombinant HIV-1 Nef protein involving the calcium/calmodulin-dependent phosphodiesterase signal transduction pathway. Proc. Natl. Acad. Sci. USA 94: 3178-3182, 1997. PubMed:
40484: Reid YA , et al. Cell Line Cross-contamination of U-937. J. Leukocyte Biol. 57: 804, 1995. PubMed:
58042: Sundstrom C , Nilsson K . Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int. J. Cancer 17: 565-577, 1976. PubMed:
178611